| Literature DB >> 30237660 |
Miłosz Czuba1, Olga Fidos-Czuba1, Kamila Płoszczyca1, Adam Zając1, Józef Langfort1.
Abstract
The aim of the study was to compare the effect of intermittent hypoxic training (IHT) and the live high, train low strategy on aerobic capacity and sports performance in off-road cyclists in normoxia. Thirty off-road cyclists were randomized to three groups and subjected to 4-week training routines. The participants from the first experimental group were exposed to normobaric hypoxia conditions (FiO2 = 16.3%) at rest and during sleep (G-LH-TL; n=10; age: 20.5 ± 2.9 years; body height 1.81 ± 0.04 m; body mass: 69.6 ± 3.9 kg). Training in this group was performed under normoxic conditions. In the second experimental group, study participants followed an intermittent hypoxic training (IHT, three sessions per week, FiO2 = 16.3%) routine (G-IHT; n=10; age: 20.7 ± 3.1 years; body height 1.78 ± 0.05 m; body mass: 67.5 ± 5.6 kg). Exercise intensity was adjusted based on the lactate threshold (LT) load determined in hypoxia. The control group lived and trained under normoxic conditions (G-C; n=10; age: 21.8 ± 4.0 years; body height 1.78 ± 0.03 m; body mass: 68.1 ± 4.7 kg; body fat content: 8.4 ± 2.4%). The evaluations included two research series (S1, S2). Between S1 and S2, athletes from all groups followed a similar training programme for 4 weeks. In each research series a graded ergocycle test was performed in order to measure VO2max and determine the LT and a simulated 30 km individual time trial. Significant (p<0.05) improvements in VO2max, VO2LT, WRmax and WRLT were observed in the G-IHT (by 3.5%, 9.1%, 6.7% and 7.7% respectively) and G-LH-TL groups (by 4.8%, 6.7%, 5.9% and 4.8% respectively). Sports performance (TT) was also improved (p<0.01) in both groups by 3.6% in G-LH-TL and 2.5% in G-IHT. Significant changes (p<0.05) in serum EPO levels and haematological variables (increases in RBC, HGB, HCT and reticulocyte percentage) were observed only in G-LH-TL. Normobaric hypoxia has been demonstrated to be an effective ergogenic aid that can enhance the exercise capacity of cyclists in normoxia. Both LH-TL and IHT lead to improvements in aerobic capacity. The adaptations induced by both approaches are likely to be caused by different mechanisms. The evaluations included two research series (S1, S2). Between S1 and S2, athletes from all groups followed a similar training programme for 4 weeks. In each research series a graded ergocycle exercise test was performed in order to measure VO2max and determine the lactate threshold as well as a simulated 30 km individual time trial.Entities:
Keywords: Cycling; Endurance training; Hypoxia; Intermittent hypoxic training; Live high train low
Year: 2017 PMID: 30237660 PMCID: PMC6135973 DOI: 10.5114/biolsport.2018.70750
Source DB: PubMed Journal: Biol Sport ISSN: 0860-021X Impact factor: 2.806
Cardiopulmonary indices at maximal and threshold loads in the experimental groups (G-LH-TL, G-IHT) and the control group (G-C) before and after the intervention.
| Variable | G-LH-TL | G-IHT | G-C | |||
|---|---|---|---|---|---|---|
| Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | |
| WRmax (W) | 370 | 391 | 385 | 410 | 370 | 374 |
| WRLT(W) | 292 | 306 | 286 | 308 | 260 | 268 |
| VO2 max (l/min) | 4.58 | 4.81 | 4.55 | 4.71 | 4.54 | 4.54 |
| VO2max(ml/kg/min) | 66.0 | 68.9 | 67.6 | 69.9 | 67.0 | 67.1 |
| VO2LT(l/min) | 3.86 | 4.12 | 3.72 | 4.06 | 3.5 | 3.59 |
| VO2LT(ml/kg/min) | 55.9 | 59.5 | 55.8 | 60.0 | 51.6 | 53.7 |
| VEmax (l/min) | 165.1 | 165.7 | 169.6 | 181.8 | 172.8 | 169.8 |
| BFmax (1/min) | 57.5 | 58.8 | 59.6 | 65.0 | 61.5 | 60.4 |
| RERmax | 1.09 | 1.08 | 1.09 | 1.11 | 1.09 | 1.09 |
| HRmax (bpm) | 191 | 192 | 195 | 192 | 196 | 194 |
p<0.05;
p<0.01;
<0.001 – statistically significant differences compared to the pre-test values.
WRmax – maximal power; WRLT – power at lactate threshold; VO2max – maximal oxygen uptake; VO2LT – oxygen uptake at lactate threshold; VEmax – maximal minute ventilation; BFmax – maximal breathing frequency; RERmax – respiratory exchange ratio; HRmax – maximal heart rate.
FIG. 1Changes in resting heart rates of studied athletes measured immediately after waking up in the lying position; ***<0.001 – statistically significant differences compared to the pre-test values.
FIG. 2Oxygen saturation of haemoglobin (SpO2) measured immediately after waking up in the lying position in the experimental group (G-LH-TL) during the study; ***<0.001 – statistically significant differences compared to the pre-test values.
Trial time (TT), average power (Pavg), and average heart rate (HRavg) registered in the study groups during the time trial, before and after completion of the experiment.
| Variable | G-LH-TL | G-IHT | G-C | |||
|---|---|---|---|---|---|---|
| Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | |
| Time Trial (s) | 3052 | 2943 | 3073 | 2999 | 3154.9 | 3116.3 |
| Pavg (W) | 316.3 | 334.3 | 307.8 | 323.8 | 298.0 | 303.7 |
| HRavg (bpm) | 182 | 181 | 179 | 176 | 175 | 175 |
p<0.01;
<0.001 – statistically significant differences compared to the pre-test values.
FIG. 3Blood serum EPO levels in the experimental and control groups during the experiment; ** p<0.01; ***<0.001 – statistically significant differences with respect to initial examinations.
Haematological indices in the experimental and control groups during initial and final evaluations.
| Variable | G-LH-TL | G-IHT | G-C | |||
|---|---|---|---|---|---|---|
| Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | |
| RBC (mln/μl) | 4.98 | 5.29 | 4.94 | 4.96 | 5.01 | 5.09 |
| HGB (g/dl) | 15.2 | 16.2 | 15.2 | 15.1 | 15.1 | 15.3 |
| HCT (%) | 44.2 | 46.5 | 43.7 | 43.9 | 44.2 | 44.6 |
| Reticulocytes (%) | 0.97 | 1.34 | 0.96 | 0.97 | 0.97 | 1.01 |
p<0.05;
<0.01 – statistically significant differences compared to the pre-test values.
RBC – red blood cell count; HGB – hemoglobin concentration; HCT – hematocrit; Reticulocytes (%) - blood reticulocyte percentage
FIG. 4Hemoglobin concentrations in the experimental and control groups during the experiment; ** p<0.01; – statistically significant differences with respect to initial examinations.
FIG. 5Percentage reticulocyte concentration in the experimental and control groups during the experiment; * p<0.05; **<0.01 – statistically significant differences with respect to initial examinations.
Lactate concentration (LA) and blood pH in study participants during the graded exercise test before and after the training programme.
| Variable | G-LH-TL | G-IHT | G-C | |||
|---|---|---|---|---|---|---|
| Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | Before (x±SD) | After (x±SD) | |
| LAmax (mmol/l) | 10.56 | 10.46 | 9.61 | 10.87 | 9.58 | 10.1 |
| ΔLA (mmol/l) | 8.94 | 8.88 | 7.79 | 9.03 | 7.74 | 8.23 |
| ΔLA12’res (mmol/l) | -2.71 | -3.74 | -1.82 | -2.56 | -1.9 | -2.88 |
| pHafter | 7.246 | 7.239 | 7.264 | 7.227 | 7.251 | 7.239 |
| ΔpH | 0.167 | 0.175 | 0.158 | 0.194 | 0.163 | 0.184 |
p<0.05;
<0.01 – statistically significant differences compared to the pre-test values.
LAmax – maximal lactate concentration, ΔLA – difference between maximal and resting lactate levels; ΔLA12’res – difference between maximal lactate concentration and the concentration after 12 min of recovery; pHpo – post-exercise blood pH; ΔpH – difference between resting and post-exercise blood pH.
Training load and changes in selected biochemical indices of muscle fatigue in particular study groups during the experiment.
| Variable | Group | Measurement | ||||
|---|---|---|---|---|---|---|
| Before (x±SD) | After (x±SD) | |||||
| Week 1 | Week 2 | Week 3 | Week 4 | |||
| Training load (TSS) | G-LH-TL | - | 1094 | 1147 | 1283 | 412 |
| G-IHT | - | 1128 | 1164 | 1276 | 387 | |
| G-C | - | 1152 | 1194 | 1308 | 426 | |
| CK (U/I) | G-LH-TL | 90.1 | 139.3 | 159.7 | 161.7 | 98.7 |
| G-IHT | 110.9 | 151.8 | 168.1 | 175.1 | 115.8 | |
| G-C | 89.3 | 147.2 | 158.8 | 161.7 | 108.4 | |
| LDH (U/I) | G-LH-TL | 274.3 | 289.4 | 305.7 | 312.1 | 248.1 |
| G-IHT | 282.4 | 295.1 | 291.6 | 321.7 | 278.2 | |
| G-C | 302.4 | 298.4 | 318.14 | 335.1 | 296.7 | |
| URIC (mg/dl) | G-LH-TL | 4.75 | 4.98 | 5.65 | 5.81 | 4.79 |
| G-IHT | 4.83 | 5.12 | 5.74 | 5.97 | 4.89 | |
| G-C | 4.91 | 5.21 | 5.84 | 6.01 | 4.87 | |
p<0.05 – statistically significant differences compared to the pre-test values.
CK – activity of creatine kinase, LDH – lactate dehydrogenase activity, URIC – uric acid activity.